204 related articles for article (PubMed ID: 28665450)
1. Predicting miRNA targets for head and neck squamous cell carcinoma using an ensemble method.
Gao H; Jin H; Li G
Int J Biol Markers; 2018 Jan; 33(1):87-93. PubMed ID: 28665450
[TBL] [Abstract][Full Text] [Related]
2. An ensemble method integrated with miRNA expression data for predicting miRNA targets in stomach adenocarcinoma.
Liu GW; Qin ZM; Shen QH
Cancer Biomark; 2017 Dec; 20(4):617-625. PubMed ID: 28800320
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.
Sass S; Pitea A; Unger K; Hess J; Mueller NS; Theis FJ
Int J Mol Sci; 2015 Dec; 16(12):30204-22. PubMed ID: 26694379
[TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
6. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
7. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
El Baroudi M; Machiels JP; Schmitz S
Cancer Biol Ther; 2017 Oct; 18(10):775-782. PubMed ID: 28886272
[TBL] [Abstract][Full Text] [Related]
8. MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
Wang H; Zhang G; Wu Z; Lu B; Yuan D; Li X; Lu Z
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C216-21. PubMed ID: 26506880
[TBL] [Abstract][Full Text] [Related]
9. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
10. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
11. The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):3-13. PubMed ID: 27557665
[TBL] [Abstract][Full Text] [Related]
12. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
13. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
Zhao G; Fu Y; Su Z; Wu R
Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
[TBL] [Abstract][Full Text] [Related]
14. Subpath analysis of each subtype of head and neck cancer based on the regulatory relationship between miRNAs and biological pathways.
An F; Zhang Z; Xia M; Xing L
Oncol Rep; 2015 Oct; 34(4):1745-54. PubMed ID: 26239836
[TBL] [Abstract][Full Text] [Related]
15. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
16. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Hui L; Wu H; Yang N; Guo X; Jang X
Oncol Rep; 2016 Jun; 35(6):3321-30. PubMed ID: 27035560
[TBL] [Abstract][Full Text] [Related]
18. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
19. Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data.
Wang B; Wang T; Cao XL; Li Y
Genet Mol Res; 2015 Dec; 14(4):17406-15. PubMed ID: 26782382
[TBL] [Abstract][Full Text] [Related]
20. Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation.
Cai J; Yu Y; Xu Y; Liu H; Shou J; You L; Jiang H; Han X; Xie B; Han W
Oral Oncol; 2019 Sep; 96():153-160. PubMed ID: 31422208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
